diabetestalk.net

Mouthwash May Trigger Diabetes—If You Use Way, Way Too Much Of It

Mouthwash May Trigger Diabetes—If You Use Way, Way Too Much of It

Mouthwash May Trigger Diabetes—If You Use Way, Way Too Much of It

Update | A new study claims very, very frequent mouthwash use is associated with a higher risk of developing type 2 diabetes. However, don’t clear it all out of your bathroom cabinet just yet. The association only existed for people who were using mouthwash at least twice a day, and the study only included people who had a number of pre-existing factors that put them at higher risk for developing the conditions.
The study, published on September 20 in Nitric Oxide, used data from 945 overweight or obese people who joined the San Juan Overweight Adults Longitudinal Study, based in Puerto Rico.
“Participants who used mouthwash at least twice daily had 55 percent significantly increased risk of developing pre-diabetes or diabetes over a 3-year follow-up compared to less frequent users, and 49 percent higher risk compared to non-users of mouthwash,” the authors wrote. Specifically, 30 percent of the group that used mouthwash at least twice a day developed one of the two conditions; that number was 10 percentage points less in the group of people who used mouthwash less frequently.
“There is no reason to believe it is restricted to overweight and obese people,” epidemiologist Kaumudi Joshipura told Newsweek, though being overweight is itself a risk factor for developing diabetes and prediabetes. ”We can’t know for sure, but at the same time, if I had to guess I think it may be generalizable to other populations.”
However, the study doesn’t show conclusively that mouthwash is causing diabetes. It only shows an association between significant usage and the diseas Continue reading

Rate this article
Total 1 ratings
Feline Diabetes: The Influence of Diet

Feline Diabetes: The Influence of Diet

Feline diabetes mellitus is similar to human type II diabetes, also known as non-insulin dependent diabetes. In these patients, the pancreas is able to produce insulin, though it is not enough to adequately control blood sugar. This may be due to damage from inflammation of the pancreas, overwork/exhaustion of the pancreas due to chronically elevated blood sugar and/or if the cells of the body have become somewhat resistant to insulin. Whatever the cause or causes, the end result is the insulin produced by the pancreas is no longer enough to control blood sugar.¹ Glucose is a sugar, so the terms blood glucose and blood sugar are used interchangeably.
Certain disease states can contribute to or cause diabetes if they damage the pancreas or cause sustained increases in blood sugar. These conditions include pancreatitis, which is inflammation of the pancreas, hormonal diseases such as hyperthyroidism or hyperadrenocorticism, and persistent infection, such as that from chronic dental infection. Certain pharmaceutical drugs that cause increases in blood glucose, most notably steroids, may also contribute to diabetes in cats.² Lastly, obesity contributes to diabetes. Obesity in cats leads to peripheral insulin resistance. A substance called amyloid which interferes with pancreatic function has also been found to be present in the pancreas of obese cats.³ Certain breeds of cats seem more likely to develop diabetes, primarily Burmese cats.
The more common reasons for obesity and peripheral insulin resistance in cats however, are quite simple. An inappropriately high-carbohydrate Continue reading

Do you have diabetes, liver disease? Watch out for CVD

Do you have diabetes, liver disease? Watch out for CVD

A study analyzing the medical data of more than 133,000 people shows that those with diabetes and a medical history of non-alcoholic fatty liver disease have a significantly higher risk of cardiovascular disease and mortality.
Recent data suggest that non-alcoholic fatty liver disease (NAFLD) is the most common type of liver disease affecting people in the United States. NAFLD is defined by a range of conditions determined by excess fat accumulating in the liver.
Liver disease is also associated with a high risk of developing cardiovascular disease (CVD) and brings an elevated risk of mortality. At the same time, studies have shown that there is a strong association between NAFLD and type 2 diabetes. Often, when the two conditions coexist, they augment the probability of developing other complications.
However, although diabetes and NAFLD so commonly occur together, and although NAFLD is associated with a risk of CVD and death, no studies so far have conclusively shown that people with both NAFLD and diabetes are also more exposed to CVD and mortality.
But now, Prof. Sarah Wild, from the University of Edinburgh, and Prof. Christopher Byrne, from the University of Southampton - both in the United Kingdom - have analyzed data from hospital records to confirm this risk in people with NAFLD and diabetes.
They have recently presented their findings at the European Association for the Study of Diabetes Annual Meeting, held in Lisbon, Portugal.
Higher CVD incidence, doubled death risk
To test for a higher risk of mortality and CVD in people with both diabetes and NAFLD, the resear Continue reading

New health ALERT: Statins raise risk of diabetes by 30%

New health ALERT: Statins raise risk of diabetes by 30%

Long-term use of the cholesterol-busting pills was linked with an increased risk of Type 2 diabetes of up to 30 per cent.
Statins, which cost just a few pence, are the most commonly prescribed drugs in Britain, with six million people taking them.
But they are controversial because they have been linked with causing muscle weakness. Other patients have complained of muscle aches, memory loss, kidney problems and sleep disturbance.
Doctors last night urged people prescribed statins to continue with their medication but warned that they should take extra steps to maintain a healthy lifestyle and reduce their diabetes risk.
Symptoms of diabetes
Fri, August 19, 2016
Diabetes is a common life-long health condition. There are 3.5 million people diagnosed with diabetes in the UK and an estimated 500,000 who are living undiagnosed with the condition.
In the first study of its kind, researchers focused on the development of diabetes among more than 3,200 statin users.
Over 10 years, statin use was linked to a 36 per cent increased risk of being diagnosed with type 2 diabetes, falling to 27 per cent after taking into account other risk factors.
More than four million Britons have type 2 diabetes and 12 million more are at risk of developing it.
The condition can lead to blindness, amputation of limbs, heart disease and stroke. Pav Kalsi, senior clinical adviser at Diabetes UK, said: “Statins can significantly reduce the risk of heart attacks and stroke, so it is important that people who have been prescribed statins continue to take them.
“If they have any concerns about the medi Continue reading

Diabetes Management Guidelines

Diabetes Management Guidelines

Source: American Diabetes Association. Standards of medical care in diabetes—2016.
Diabetes Care. 2016;39(suppl 1):S1-S106. Available here.
Refer to source document for full recommendations, including class of recommendation and level of evidence.
Jump to a topic or click back/next at the bottom of each page
Cardiovascular Disease (CVD) & Diabetes
Blood Pressure (Hypertension) Management & Treatment Targets
Screening
Measure BP at every patient visit
Confirm elevated BP at a separate visit
Treatment targets
Systolic (SBP) targets
<140 mm Hg
Lower target (<130) may be appropriate in certain individuals*
Diastolic (DBP) targets
<90 mm Hg
Lower target (<80) may be appropriate in certain individuals*
*Younger individuals, people with albuminuria, and/or individuals with hypertension and one or more additional ASCVD risk factor
Only if the lower target can be achieved without undue treatment burden
Treatment of High Blood Pressure
Individuals with BP >120/80 mm Hg
Lifestyle changes (See below)
Individuals with confirmed office BP >140/90 mm Hg
Prompt initiation and timely subsequent titration of pharmacologic therapy (see below) in addition to lifestyle changes
Older adults
Treating to <130/70 mm Hg is not recommended
SBP <130 has not been shown to improve CV outcomes
DBP <70 has been associated with increased mortality
Pregnant individuals
Targets of 110-129/65-79 are recommended to optimize long-term maternal health and minimize impaired fetal growth
Pharmacologic Therapy for High Blood Pressure
Regimen to include ACEI or ARB—but never in combination
If either ACEI or ARB Continue reading

No more pages to load

Popular Articles

Related Articles